Rokicka-Milewska R, Derulska D, Jackowska T, Armata J, Balwierz W, Bogusławska-Jaworska J, Chybicka A, Cyklis R, Duczmal B, Jakowicka M
Katedry i Kliniki Pediatrii, Hematologii i Onkologii AM, Warszawie.
Acta Haematol Pol. 1992;23(1):43-7.
In the group of 63 children in whom a relapse of ALL after first suspension of treatment occurred, and in whom a repeated cessation of therapy had place, 46.2% of patients had probability of a prolonged symptomless survival. The children with an isolated extramedullary relapse had a greater chance for a DFS of 7 years, than those with a relapse in the bone marrow (p = 0.05). The patients with a relapse occurring after the first cessation of treatment of ALL should be treated as intensively as newly diagnosed cases, because they have a real possibility for a prolonged survival during remission phase of disease.
在63名首次中止治疗后出现急性淋巴细胞白血病复发且再次停止治疗的儿童中,46.2%的患者有症状持续缓解生存的可能性。孤立性髓外复发的儿童比骨髓复发的儿童有更大的机会实现7年无病生存(p = 0.05)。急性淋巴细胞白血病首次停止治疗后复发的患者应像新诊断病例一样接受强化治疗,因为他们在疾病缓解期有实现长期生存的切实可能性。